Evaluating the Impact of Medicare Part D on Persons with Severe Mental Illness
neuroscienceCME Webcast
Premiere Date: Wednesday, February 6, 2008Additional Webcast Date:
Wednesday, February 27, 2008
12:00 PM - 1:00 PM ET
This activity offers CE credit for:
- Physicians (ACCME/AMA PRA Category 1)
- Nurses (CNE)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
Credit Expiration Date:
Friday, February 27, 2009
 | MODERATOR: Daniel Carpenter, PhD Senior Vice President Chief Information Officer Comprehensive NeuroScience, Inc. White Plains, NY |
 | Carol L. Alter, MD Associate Professor of Psychiatry Director of Policy and Community Outreach Georgetown University Hospital Washington, DC |
 | Elizabeth V. Delesante, MD Psychiatrist Central Lakes Medical Clinic Crosby, MN |
Faculty Bios and Disclosure Declaration
Click here to view faculty bios and activity disclosures.
Patients with severe mental illness (SMI) have a higher prevalence of medical conditions than the general
population, and generate more than twice the overall healthcare costs.(1) Contributing to this problem
are the general under-recognition of medical conditions in patients with SMI and their general lack of
access to quality care.(2) Thus, it is not surprising that patients with SMI are substantially impacted by policy
decisions that revise Medicaid eligibility standards, lower payments to providers, and complicate access
to new medications in an attempt to control rising healthcare costs. In particular, the implementation of
Medicare (MMA) Part D, which shifted pharmacy dollars to Medicare for dually eligible individuals, has had
a significant impact on this population. A recent survey of psychiatrists indicated that MMA Part D has
contributed to confusion and problems for physicians in maintaining continuity of care for SMI patients.(3)
This situation has created a strong impetus for expanding strategies for delivering highly cost-effective care
to SMI patients. In this interactive webcast, faculty will review key components of MMA Part D that impact
SMI patients and identify strategies to ensure continuous care and maximize the likelihood of a positive
outcome.
- Buck J, Teich J, Miller K. Use of mental health and substance abuse services among high-cost Medicaid enrollees. Adm Policy Ment Health 2003;31:3-14.
- Nasrallah H. An overview of common comorbidities in patients with schizophrenia. J Clin Psychiatry 2005;66:3-4.
- West JC, Wilk JE, Muszynski IL, et al. Medication access and continuity: the experiences of dual-eligible psychiatric patients during the first 4 months of the Medicare prescription drug benefit. Am J Psychiatry 2007;164:700-701.
The goal of this activity is to educate practitioners about the impact of Medicare Part D on patients with severe mental illness and to provide guidance on strategies for delivering optimal care to these patients in light of policy restrictions.
At the end of this CE activity, participants should be able to:
- Identify the ways in which Medicare Part D impacts patients.
- Describe the clinical challenges posed by Medicare Part D.
- Delineate strategies for obtaining Medicare authorization for optimal pharmacotherapy.
Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals who treat patients with severe mental illness.
CME Outfitters, LLC, gratefully acknowledges an educational grant from Eli Lilly and Company in support of this CE activity.
CME Credit (Physicians):
This activity has been planned and
implemented in accordance with the Essential
Areas and Policies of the Accreditation Council
for Continuing Medical Education through
the joint sponsorship of CME Outfitters, LLC, and Expert
Knowledge Systems, an educational division of Comprehensive
NeuroScience, Inc. CME Outfitters, LLC, is accredited by the
ACCME to provide continuing medical education for physicians.
CME Outfitters, LLC, designates this educational activity for
a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Note to Physician Assistants: AAPA accepts Category I credit from AOACCME, Prescribed credit from AAFP, and AMA Category I CME credit for the PRA from organizations accredited by ACCME.
CNE Credit (Nurses):
CME Outfitters, LLC, is an approved
provider of continuing nursing education by the New York State
Nurses Association, an accredited approver by the American
Nurses Credentialing Center’s Commission on Accreditation.
It has been assigned code 6WASUP-PRV-0630. 1.0 contact hours will be awarded upon successful completion. This activity is co-provided with Expert Knowledge Systems, an educational
division of Comprehensive NeuroScience, Inc.
Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.
CEP Credit (Psychologists):
CME Outfitters is approved by
the American Psychological Association to sponsor continuing
education for psychologists. CME Outfitters maintains
responsibility for this program and its content. (1.0 CE credits)
NASW Credit (Social Workers):
This program was approved
by the National Association of Social Workers (provider
#886407722) for 1 continuing education contact hour.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 1.0 contact hours (0.1 CEUs)
Universal Program Number: 376-999-08-006-L01-P (live presentation) 376-999-08-006-H01-P (recorded programs)
Post-tests, credit request forms, and activity evaluations can be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Activities tab - requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required).
Joint Sponsorship
CME Outfitters gratefully acknowledges the contributions of Expert Knowledge Systems, an educational division of Comprehensive NeuroScience, Inc., as its joint sponsor for this continuing education activity.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).
WC-002-020608-11
